These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26900728)

  • 21. Vaccine Coverage for United States Infants at Milestone Ages: Missed Opportunities for Vaccination.
    Gebremeskel BG; Zhang D; Goveia MG; Marshall GS; O'Brien MA
    J Pediatric Infect Dis Soc; 2016 Dec; 5(4):473-475. PubMed ID: 27503832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measurement of coverage, compliance and determinants of uptake in a publicly funded rotavirus vaccination programme: a retrospective cohort study.
    Rafferty E; Guo X; McDonald B; Svenson LW; MacDonald SE
    BMJ Open; 2019 Nov; 9(11):e031718. PubMed ID: 31678951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety profile of rotavirus vaccines among individuals aged ≥8 months of age, United States, vaccine adverse event reporting system (VAERS), 2006-2019.
    Haber P; Tate J; Marquez PL; Moro PL; Parashar U
    Vaccine; 2021 Jan; 39(4):746-750. PubMed ID: 33267969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of pentavalent rotavirus vaccination in neonatal intensive care units.
    Thrall S; Doll MK; Nhan C; Gonzales M; Perreault T; Lamer P; Quach C
    Vaccine; 2015 Sep; 33(39):5095-102. PubMed ID: 26296493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of the pentavalent rotavirus vaccine in preventing gastroenteritis in the United States.
    Wang FT; Mast TC; Glass RJ; Loughlin J; Seeger JD
    Pediatrics; 2010 Feb; 125(2):e208-13. PubMed ID: 20100757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Public health impact of Rotarix vaccination among commercially insured children in the United States.
    Krishnarajah G; Kageleiry A; Korves C; Lefebvre P; Duh MS
    Vaccine; 2017 Sep; 35(37):5065-5072. PubMed ID: 28778611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Timeliness and factors associated with rotavirus vaccine uptake among Australian Aboriginal and non-Aboriginal children: A record linkage cohort study.
    Fathima P; Gidding HF; Snelling TL; McIntyre PB; Blyth CC; Sheridan S; Liu B; de Klerk N; Moore HC
    Vaccine; 2019 Sep; 37(39):5835-5843. PubMed ID: 31443995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccination with 3-dose paediatric rotavirus vaccine (RotaTeq®): impact on the timeliness of uptake of the primary course of DTPa vaccine.
    Wendy B
    Vaccine; 2012 Jul; 30(35):5293-7. PubMed ID: 22575163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Parashar UD; Alexander JP; Glass RI;
    MMWR Recomm Rep; 2006 Aug; 55(RR-12):1-13. PubMed ID: 16902398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of 2 rotavirus vaccines against rotavirus disease in Taiwanese infants.
    Chang WC; Yen C; Wu FT; Huang YC; Lin JS; Huang FC; Yu HT; Chi CL; Lin HY; Tate JE; Parashar UD; Wu HS; Hsiung CA
    Pediatr Infect Dis J; 2014 Mar; 33(3):e81-6. PubMed ID: 24569388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants.
    Shui IM; Baggs J; Patel M; Parashar UD; Rett M; Belongia EA; Hambidge SJ; Glanz JM; Klein NP; Weintraub E
    JAMA; 2012 Feb; 307(6):598-604. PubMed ID: 22318281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua.
    Patel M; Pedreira C; De Oliveira LH; Tate J; Orozco M; Mercado J; Gonzalez A; Malespin O; Amador JJ; Umaña J; Balmaseda A; Perez MC; Gentsch J; Kerin T; Hull J; Mijatovic S; Andrus J; Parashar U
    JAMA; 2009 Jun; 301(21):2243-51. PubMed ID: 19491186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccine discontinuation and switching following regulatory interventions in response to rotavirus vaccine contamination with porcine circovirus DNA fragments.
    Dore DD; Turnbull BR; Seeger JD
    Pharmacoepidemiol Drug Saf; 2012 Apr; 21(4):415-9. PubMed ID: 22290786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of Rotavirus Nosocomial Spread After Inpatient Pentavalent Rotavirus Vaccination.
    Hofstetter AM; Lacombe K; Klein EJ; Jones C; Strelitz B; Jacobson E; Ranade D; Ward ML; Mijatovic-Rustempasic S; Evans D; Wikswo M; Bowen MD; Parashar UD; Payne DC; Englund JA
    Pediatrics; 2018 Jan; 141(1):. PubMed ID: 29212881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine as a five-dose series. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 2000 Nov; 49(RR-13):1-8. PubMed ID: 11106289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and cost burden of rotavirus infection before and after introduction of rotavirus vaccines among commercially and Medicaid insured children in the United States.
    Krishnarajah G; Demissie K; Lefebvre P; Gaur S; Sheng Duh M
    Hum Vaccin Immunother; 2014; 10(8):2255-66. PubMed ID: 25424930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Completion and compliance of childhood vaccinations in the United States.
    Kurosky SK; Davis KL; Krishnarajah G
    Vaccine; 2016 Jan; 34(3):387-94. PubMed ID: 26597149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1997 Mar; 46(RR-7):1-25. PubMed ID: 9091780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule.
    Buttery JP; Lambert SB; Grimwood K; Nissen MD; Field EJ; Macartney KK; Akikusa JD; Kelly JJ; Kirkwood CD
    Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S25-9. PubMed ID: 21183837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.